Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2006

01-01-2006

Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy

Authors: J.L. Grabinski, L.S. Smith, G.B. Chisholm, R. Drengler, G.I. Rodriguez, A.S. Lang, S.P. Kalter, A.M. Garner, L.M. Fichtel, J. Hollsten, B.H. Pollock, J.G. Kuhn

Published in: Breast Cancer Research and Treatment | Issue 1/2006

Login to get access
Metadata
Title
Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy
Authors
J.L. Grabinski
L.S. Smith
G.B. Chisholm
R. Drengler
G.I. Rodriguez
A.S. Lang
S.P. Kalter
A.M. Garner
L.M. Fichtel
J. Hollsten
B.H. Pollock
J.G. Kuhn
Publication date
01-01-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-9019-5

Other articles of this Issue 1/2006

Breast Cancer Research and Treatment 1/2006 Go to the issue

Letter to the editor

Can the apparent conflicting roles of PKC δ on cell proliferation and survival be reconciled?

Clinical trial

Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer

OriginalPaper

Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer

Epidemiology

A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients

OriginalPaper

Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation

Epidemiology

The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits